Literature DB >> 17431506

Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.

Omar Nelson1, Huiping Tu, Tianhua Lei, Mostafa Bentahir, Bart de Strooper, Ilya Bezprozvanny.   

Abstract

Mutations in presenilins are responsible for approximately 40% of all early-onset familial Alzheimer disease (FAD) cases in which a genetic cause has been identified. In addition, a number of mutations in presenilin-1 (PS1) have been suggested to be associated with the occurrence of frontal temporal dementia (FTD). Presenilins are highly conserved transmembrane proteins that support cleavage of the amyloid precursor protein by gamma-secretase. Recently, we discovered that presenilins also function as passive ER Ca(2+) leak channels. Here we used planar lipid bilayer reconstitution assays and Ca(2+) imaging experiments with presenilin-null mouse embryonic fibroblasts to analyze ER Ca(2+) leak function of 6 FAD-linked PS1 mutants and 3 known FTD-associated PS1 mutants. We discovered that L166P, A246E, E273A, G384A, and P436Q FAD mutations in PS1 abolished ER Ca(2+) leak function of PS1. In contrast, A79V FAD mutation or FTD-associated mutations (L113P, G183V, and Rins352) did not appear to affect ER Ca(2+) leak function of PS1 in our experiments. We validated our findings in Ca(2+) imaging experiments with primary fibroblasts obtained from an FAD patient possessing mutant PS1-A246E. Our results indicate that many FAD mutations in presenilins are loss-of-function mutations affecting ER Ca(2+) leak activity. In contrast, none of the FTD-associated mutations affected ER Ca(2+) leak function of PS1, indicating that the observed effects are disease specific. Our observations are consistent with the potential role of disturbed Ca(2+) homeostasis in Alzheimer disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431506      PMCID: PMC1847535          DOI: 10.1172/JCI30447

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  The Thr354Ile substitution in PSEN1:: disease-causing mutation or polymorphism?

Authors:  Peiyee Lee; Luis Medina; John M Ringman
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

2.  Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.

Authors:  Mostafa Bentahir; Omar Nyabi; Jan Verhamme; Alexandra Tolia; Katrien Horré; Jens Wiltfang; Hermann Esselmann; Bart De Strooper
Journal:  J Neurochem       Date:  2006-01-09       Impact factor: 5.372

3.  Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.

Authors:  Giancarlo Zatti; Andrea Burgo; Marta Giacomello; Laura Barbiero; Roberta Ghidoni; Giulietta Sinigaglia; Cristina Florean; Silvia Bagnoli; Giuliano Binetti; Sandro Sorbi; Paola Pizzo; Cristina Fasolato
Journal:  Cell Calcium       Date:  2006-04-18       Impact factor: 6.817

4.  Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment.

Authors:  Cezary Zekanowski; Maciej P Golan; Krystiana A Krzyśko; Wanda Lipczyńska-Łojkowska; Sławomir Filipek; Anna Kowalska; Grzegorz Rossa; Beata Pepłońska; Maria Styczyńska; Aleksandra Maruszak; Dorota Religa; Mieczysław Wender; Jerzy Kulczycki; Maria Barcikowska; Jacek Kuźnicki
Journal:  Exp Neurol       Date:  2006-03-20       Impact factor: 5.330

Review 5.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

6.  Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations.

Authors:  Huiping Tu; Omar Nelson; Arseny Bezprozvanny; Zhengnan Wang; Sheu-Fen Lee; Yi-Heng Hao; Lutgarde Serneels; Bart De Strooper; Gang Yu; Ilya Bezprozvanny
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

Review 7.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Bart De Strooper
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

8.  Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway.

Authors:  Dragana Spasic; Alexandra Tolia; Katleen Dillen; Veerle Baert; Bart De Strooper; Stefan Vrijens; Wim Annaert
Journal:  J Biol Chem       Date:  2006-07-14       Impact factor: 5.157

9.  Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.

Authors:  E Ito; K Oka; R Etcheberrigaray; T J Nelson; D L McPhie; B Tofel-Grehl; G E Gibson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study.

Authors:  Bradley F Boeve; Matt Baker; Dennis W Dickson; Joseph E Parisi; Caterina Giannini; Keith A Josephs; Michael Hutton; Stuart M Pickering-Brown; Rosa Rademakers; David Tang-Wai; Clifford R Jack; Kejal Kantarci; Maria M Shiung; Todd Golde; Glenn E Smith; Yonas E Geda; David S Knopman; Ronald C Petersen
Journal:  Brain       Date:  2006-10-09       Impact factor: 13.501

View more
  102 in total

1.  Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.

Authors:  Gary E Gibson; Huan-Lian Chen; Hui Xu; Linghua Qiu; Zuoshang Xu; Travis T Denton; Qingli Shi
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

Review 2.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

3.  Role of presenilins in neuronal calcium homeostasis.

Authors:  Hua Zhang; Suya Sun; An Herreman; Bart De Strooper; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

4.  Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk.

Authors:  Enrico Zampese; Cristina Fasolato; Maulilio J Kipanyula; Mario Bortolozzi; Tullio Pozzan; Paola Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

Review 5.  Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease.

Authors:  Bart De Strooper; Takeshi Iwatsubo; Michael S Wolfe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 6.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

7.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

8.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

Review 9.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

10.  Store depletion-induced h-channel plasticity rescues a channelopathy linked to Alzheimer's disease.

Authors:  Timothy F Musial; Elizabeth Molina-Campos; Linda A Bean; Natividad Ybarra; Ronen Borenstein; Matthew L Russo; Eric W Buss; Daniel Justus; Krystina M Neuman; Gelique D Ayala; Sheila A Mullen; Yuliya Voskobiynyk; Christopher T Tulisiak; Jasmine A Fels; Nicola J Corbett; Gabriel Carballo; Colette D Kennedy; Jelena Popovic; Josefina Ramos-Franco; Michael Fill; Melissa R Pergande; Jeffrey A Borgia; Grant T Corbett; Kalipada Pahan; Ye Han; Dane M Chetkovich; Robert J Vassar; Richard W Byrne; M Matthew Oh; Travis R Stoub; Stefan Remy; John F Disterhoft; Daniel A Nicholson
Journal:  Neurobiol Learn Mem       Date:  2018-06-12       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.